An Unusual Case of Constitutional Mismatch Repair Deficiency Syndrome With Anaplastic Ganglioglioma, Colonic Adenocarcinoma, Osteosarcoma, Acute Myeloid Leukemia, and Signs of Neurofibromatosis Type 1: Case Report

Neurosurgery

Volumn 77, Issue 1, 2015, Pages E145-E152

  Daou, Badih ^a   Zanello, Marc ^b,c   Varlet, Pascale ^c,d   Brugieres, Laurence ^e   Jabbour, Pascal ^a   Caron, Olivier ^e   Lavoine, Noémie ^e   Dhermain, Frederic ^e   Willekens, Christophe ^e   Beuvon, Frederic ^f   Malka, David ^e   Lechapt Zalcmann, Emmanuèle ^g   Abi Lahoud, Georges ^b,c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b University Hospital of Sainte Anne   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f Cochin Hospital ^*  (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Anaplastic ganglioglioma; Constitutional mismatch repair deficiency syndrome

Indexed keywords

CHROMOGRANIN A; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; HYDROXYUREA; IDARUBICIN; IFOSFAMIDE; ISOCITRATE DEHYDROGENASE 1; MELPHALAN; MISMATCH REPAIR PROTEIN; MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; SYNAPTOPHYSIN; TEMOZOLOMIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; COLON ADENOCARCINOMA; CONSTITUTIONAL MISMATCH REPAIR DEFICIENCY SYNDROME; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC DISORDER; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIPLE CYCLE TREATMENT; NEUROFIBROMATOSIS TYPE 1; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; RECESSIVE INHERITANCE; SURVIVAL TIME; TOTAL COLON RESECTION; YOUNG ADULT; ADENOCARCINOMA; BONE NEOPLASMS; BRAIN NEOPLASMS; COLONIC NEOPLASMS; COLORECTAL TUMOR; COMPLICATION; FAMILIAL CANCER; GANGLIOGLIOMA; LEUKEMIA, MYELOID, ACUTE; NEUROFIBROMATOSIS 1;

ADENOCARCINOMA; BONE NEOPLASMS; BRAIN NEOPLASMS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GANGLIOGLIOMA; HUMANS; LEUKEMIA, MYELOID, ACUTE; NEOPLASTIC SYNDROMES, HEREDITARY; NEUROFIBROMATOSIS 1; OSTEOSARCOMA; YOUNG ADULT;

EID: 84931825277     PISSN: 0148396X     EISSN: 15244040     Source Type: Journal    
DOI: 10.1227/NEU.0000000000000754     Document Type: Article

References (27)

1. Felton KE, Gilchrist DM, Andrew SE. Constitutive deficiency in DNA mismatch repair. Clin Genet. 2007;71(6):483-498.
2. Herkert JC, Niessen RC, Olderode-Berends MJ, et al. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines. Eur J Cancer. 2011;47(7):965-982.
3. Kruger S, Kinzel M, Walldorf C, et al. Homozygous PMS2 germline mutations in two families with early-onset haematological malignancy, brain tumours, HNPCC-associated tumours, and signs of neurofibromatosis type 1. Eur J Hum Genet. 2008;16(1):62-72.
4. Wimmer K, Etzler J. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet. 2008;124(2):105-122.
5. Wimmer K, Kratz CP. Constitutional mismatch repair-deficiency syndrome. Haematologica. 2010;95(5):699-701.
6. Wimmer K, Kratz CP, Vasen HF, et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium "care for CMMRD" (C4CMMRD). J Med Genet. 2014;51(6):355-365.
7. Jasperson KW, Samowitz WS, Burt RW. Constitutional mismatch repair-deficiency syndrome presenting as colonic adenomatous polyposis: clues from the skin. Clin Genet. 2011;80(4):394-397.
8. Chmara M, Wernstedt A, Wasag B, et al. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency. Genes Chromosomes cancer. 2013;52(7):656-664.
9. Kratz CP, Holter S, Etzler J, et al. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome. J Med Genet. 2009;46(6):418-420.
10. Liu T, Tannergård P, Hackman P, et al. Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet. 1999;105(5):437-441.
11. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
12. Romero-Rojas AE, Diaz-Perez JA, Chinchilla-Olaya SI, Amaro D, Lozano-Castillo A, Restrepo-Escobar LI. Histopathological and immunohistochemical profile in anaplastic gangliogliomas. Neurocirugia (Astur). 2013;24(6):237-243.
13. Luyken C, Blümcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer. 2004;101(1):146-155.
14. Zentner J, Wolf HK, Ostertun B, et al. Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. J Neurol Neurosurg Psychiatry. 1994;57(12):1497-1502.
15. Lang FF, Epstein FJ, Ransohoff J, et al. Central nervous system gangliogliomas. Part 2: clinical outcome. J Neurosurg. 1993;79(6):867-873.
16. Blümcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol. 2002;61(7):575-584.
17. DeMarchi R, Abu-Abed S, Munoz D, Loch Macdonald R. Malignant ganglioglioma: case report and review of literature. J Neurooncol. 2011;101(2):311-318.
18. Zhang D, Henning TD, Zou LG, et al. Intracranial ganglioglioma: clinicopathological and MRI findings in 16 patients. Clin Radiol. 2008;63(1):80-91.
19. Selch MT, Goy BW, Lee SP, et al. Gangliogliomas: experience with 34 patients and review of the literature. Am J Clin Oncol. 1998;21(6):557-564.
20. Hakim R, Loeffler JS, Anthony DC, Black PM. Gangliogliomas in adults. Cancer. 1997;79(1):127-131.
21. Ricciardone MD, Ozçelik T, Cevher B, et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res. 1999;59(2):290-293.
22. Bakry D, Aronson M, Durno C, et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. Eur J Cancer. 2014;50(5):987-996.
23. Vasen HF, Ghorbanoghli Z, Bourdeaut F, et al. Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D). J Med Genet. 2014;51(5):283-293.
24. Yeung JT, Pollack IF, Shah S, Jaffe R, Nikiforova M, Jakacki RI. Optic pathway glioma as part of a constitutional mismatch-repair deficiency syndrome in a patient meeting the criteria for neurofibromatosis type 1. Pediatr Blood Cancer. 2013;60(1):137-139.
25. Johannesma PC, van der Klift HM, van Grieken NC, et al. Childhood brain tumours due to germline bi-allelic mismatch repair gene mutations. Clin Genet. 2011;80(3):243-255.
26. Pollack IF, Hamilton RL, Sobol RW, et al. Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group.Pediatr Blood Cancer. 2010;55(6):1066-1071.
27. Walter AW, Ennis S, Best H, et al. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies. Pediatr Blood Cancer. 2013;60(11):E135-E136.